Unmistakably
BD Oncology

Measure and improve performance in oncology management

‘What gets measured gets improved’… It may be a management cliché, but in oncology it’s critical.

Being able to track patient data across the entire care pathway is at the heart of identifying issues and then, putting solutions in place and providing more effective oncology management for your team. An integrated software solution is a crucial management tool here, as it provides clearer information and greater accuracy, from prescribing to preparing to administering medication. As a result, hard measures give real insights into how and where improved performance can be achieved.

BD Cato™ is an integrated, automated* software solution that provides support through all stages of intravenous (IV) chemotherapy prescribing, preparation and administration. By connecting processes, it can enhance communication, reduce clinical and operational errors, and eliminate many resource-intensive tasks.

Improving productivity

a saving of up to

39%

of clinical time could be made.1

BD Cato™ saved

3:24

hours of nursing time daily in a hospital oncology day unit2.

 
 

Freeing up time allows staff to be redeployed to do other critical work and value-added tasks.

Improving productivity

BD Cato™ has a measurable impact that benefits patients, healthcare staff and senior managers/directors alike within oncology.

A study showed that by combining BD’s complete oncology pathway solutions, a saving of up to 39% of clinical time could be made.1 Another study showed that BD Cato™ saved 3 hours, 24 minutes of nursing time daily in a hospital oncology day unit2. Freeing up time allows staff to be redeployed to do other critical work and value-added tasks. Capacity is unlocked and you can treat more patients with the same resources.

Helping physicians prescribe more efficiently, accurately and safely

Typically, physicians are responsible for developing treatment plans for patients. These treatment plans often involve complex drug regimens, dose calculations, and the physician has to ensure individual dose and cumulative doses’ limits are not exceeded.

With BD Cato™**, physicians prescribe treatment plans using a framework of pre-built treatment protocols, with predefined drug and dose recommendations. Past chemotherapy drug/dosage history can be viewed, and due to BD Cato™ interfacing with the hospital’s electronic medical record system, patients’ laboratory results are readily available.

With BD Cato™, automatic notifications appear to inform the physician if they have prescribed a dose outside the predefined recommended limits. However, physicians retain the ability to confirm their decision if there is a clinical reason to do so - but then it is by choice, not error.

Ensuring the treatment plan is accurate and appropriate is the first step in ensuring the right patient gets the right drug at the right dosage at the right time, helping to improve patient safety, eliminate costly errors and provide more effective oncology management.

Clarity and priority in the pharmacy

BD Cato™ eliminates time spent deciphering handwritten orders as physicians prescribe the treatment plan electronically, which is then sent directly to pharmacy. Any updates to the treatment plan by the physician can be seen in real-time by pharmacy, helping to ensure effective communication.

BD Cato™ provides oversight of the workload within pharmacy, and automatically places the most urgent prescriptions first in the queue. This real-time oncology workload management injects high levels of efficiency into the process.

Inventory and dispensing management

BD Cato™ helps to avoid delays caused by stock-outs due to providing comprehensive inventory and dispensing management. It provides complete visibility and traceability of inventory through tracking the quantity, batch numbers and expiry dates of stock, as well part-used drugs remaining after compounding. BD Cato™ suggests the most suitable vials to assemble for each dose, helping to ensure part-used vials are used up first. This can result in a reduction of drug waste and therefore deliver cost savings.

Complementing these processes is BD’s closed system drug transfer device, BD PhaSeal™. One study looking at the impact of BD PhaSeal™ showed the pharmacy avoided nearly half of the potential waste and saved a mean of 29% of each vial. That represented an annual saving in pharmacy waste alone of $703,047.673.*

Avoiding human error in compounding

Drug compounding presents multiple opportunities for human error, which can lead to increased costs and increased risk to patient safety. On top of this, many of these errors are not even detectable during the manual compounding process. A large-scale European multi-center study assessed the impact of automation* and discovered that of 759,060 chemotherapy preparations, the mean out-of-tolerance error rate during compounding was 10.44%.4 These errors were detected by the gravimetric technology. The study concluded that it is unlikely these errors would have been detected using a manual compounding process.

During compounding, BD Cato™ informs the user if there is an error, allowing it to be rectified immediately. A hardstop will prevent the user from continuing until the error has been corrected, helping to ensure patient safety. Once the dose has been correctly prepared, BD Cato™ will create a unique barcode for the final product. This barcode provides traceability of the prepared dose, helping to ensure the correct patient receives the correct drug.

Track users and actions throughout the value chain

When there has been a medication error, it can be time-consuming to identify when and where it originated. Was it a dosage error? Did the pharmacist misread the physician’s note? Did the physician over or under-dose the patient? Did the nurse select the wrong bag?

BD Cato™ tracks each user involved in a patient’s treatment pathway, and any action they performed. This provides full visibility into the value chain of each drug – enabling managers to identify problems areas, implement solutions and mitigate risk.

Empowering Nurses

Another advantage of BD Cato™ is that it empowers nurses. It does this by allowing nurses to track what stage a patient’s dose is at within the compounding process, and also create bed plans to align with their required treatment regimen. They can easily access patient information relevant to the therapy plan and can see valuable information, such as whether the patient had an adverse reaction to a previous treatment or had a delay / omission of a drug within a previous treatment cycle. All this combines to empower nurses to spend more time focused on patients, allowing them to operate with precision and efficiency.

Better management of oncology through an integrated software solution

Across the whole care pathway, BD can make a tangible difference in oncology management. BD solutions can help to:

  • Increase capacity and productivity of the pharmacy compounding service, helping to meet the growing demand for chemotherapy caused by increased patient numbers
  • Increase patient satisfaction and quality of life due to decreased waiting times for their chemotherapy because of reduced preparation time
  • Increase nurse satisfaction because of fewer dissatisfied patients
  • Increase satisfaction and motivation of pharmacy staff due to reduction of the pressures that come with manual checking
  • Free-up time for pharmacy staff to perform other value-added tasks within the department
  • Create cost savings through reduced drug wastage due to effective inventory management
  • Create cost savings through detection and correction of errors at the point they occur, which reduces frequency of remaking doses
  • Increase the ease of performing a systematic review of the metrics concerning prescribing, compounding and administration, due to electronic documentation of each step of the process.

By considering all these benefits, the potential for improvement that automation* offers in oncology management is truly transformational.

Unmistakably BD Oncology.


Contact us